Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis

Eric Chun Yet Lian, Andreas G. Tzakis, David Andrews

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sjögren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.

Original languageEnglish
Pages (from-to)363-365
Number of pages3
JournalAmerican Journal of Hematology
Volume77
Issue number4
DOIs
StatePublished - Dec 1 2004

Fingerprint

Factor V
Biliary Liver Cirrhosis
Liver Transplantation
Ecchymosis
Systemic Lupus Erythematosus
Lower Extremity
Rituximab

Keywords

  • Factor V inhibitor
  • Primary biliary cirrhosis
  • Rituximab
  • Sjögren's syndrome
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Hematology

Cite this

Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis. / Lian, Eric Chun Yet; Tzakis, Andreas G.; Andrews, David.

In: American Journal of Hematology, Vol. 77, No. 4, 01.12.2004, p. 363-365.

Research output: Contribution to journalArticle

@article{dd024b8ae9cd4419808bdb6fc5459dc8,
title = "Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis",
abstract = "A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sj{\"o}gren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.",
keywords = "Factor V inhibitor, Primary biliary cirrhosis, Rituximab, Sj{\"o}gren's syndrome, Systemic lupus erythematosus",
author = "Lian, {Eric Chun Yet} and Tzakis, {Andreas G.} and David Andrews",
year = "2004",
month = "12",
day = "1",
doi = "10.1002/ajh.20181",
language = "English",
volume = "77",
pages = "363--365",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis

AU - Lian, Eric Chun Yet

AU - Tzakis, Andreas G.

AU - Andrews, David

PY - 2004/12/1

Y1 - 2004/12/1

N2 - A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sjögren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.

AB - A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sjögren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.

KW - Factor V inhibitor

KW - Primary biliary cirrhosis

KW - Rituximab

KW - Sjögren's syndrome

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=9644299781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644299781&partnerID=8YFLogxK

U2 - 10.1002/ajh.20181

DO - 10.1002/ajh.20181

M3 - Article

C2 - 15551286

AN - SCOPUS:9644299781

VL - 77

SP - 363

EP - 365

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -